Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina

American Journal of Neurodegenerative Diseases

Volumn 1, Issue 2, 2012, Pages 168-179

  Sims, Stephanie M ^a   Holmgren, Lauren ^a   Cathcart, Heather M ^a   Sappington, Rebecca M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DBA 2; Glaucoma; Interleukin 6; Interleukin 6 receptor; Retina

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA;

AGED; AGING; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLAUCOMA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; RETINA; RETINA GANGLION CELL; SIGNAL TRANSDUCTION;

EID: 84980053096     PISSN: None     EISSN: 2165591X     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN and Wong WT. Age-related alterations in the dynamic behavior of microglia. Aging Cell 2011; 10: 263-276.
2. Morales I, Farias G and Maccioni RB. Neuroimmuno modulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 2010; 17: 202-204.
3. Brown GC and Neher JJ. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010; 41: 242-247.
4. Zhao B and Schwartz JP. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J Neurosci Res 1998; 52: 7-16.
5. Tansey MG and Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 2010; 37: 510-518.
6. Campbell IL. Structural and functional impact of the transgenic expression of cytokines in the CNS. Ann N Y Acad Sci 1998; 840: 83-96.
7. Lynch AM, Murphy KJ, Deighan BF, O'Reilly JA, Gun'ko YK, Cowley TR, Gonzalez-Reyes RE and Lynch MA. The impact of glial activation in the aging brain. Aging Dis 2010; 1: 262-278.
8. Sappington RM and Calkins DJ. Pressureinduced regulation of IL-6 in retinal glial cells: involvement of the ubiquitin/proteasome pathway and NFkappaB. Invest Ophthalmol Vis Sci 2006; 47: 3860-3869.
9. Sappington RM and Calkins DJ. Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure. Invest Ophthalmol Vis Sci 2008; 49: 3004 -3017.
10. Inman DM and Horner PJ. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 2007; 55: 942-953.
11. Coleman AL and Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol 2008; 53 Suppl1: S3-10.
12. Xu H, Chen M, Mayer EJ, Forrester JV and Dick AD. Turnover of resident retinal microglia in the normal adult mouse. Glia 2007; 55: 1189- 1198.
13. Bosco A, Steele MR and Vetter ML. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 2011; 519: 599-620.
14. Liou GI. Diabetic retinopathy: Role of inflammation and potential therapies for antiinflammation. World J Diabetes 2010; 1: 12- 18.
15. Buschini E, Piras A, Nuzzi R and Vercelli A. Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 2011; 95: 14-25.
16. Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D and Zack DJ. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci 2007; 48: 5539-5548.
17. Tezel G and Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol 2004; 15: 80- 84.
18. Hernandez MR, Miao H and Lukas T. Astrocytes in glaucomatous optic neuropathy. Prog Brain Res 2008; 173: 353-373.
19. Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog Brain Res 2008; 173: 409-421.
20. Yuan L and Neufeld AH. Tumor necrosis factoralpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000; 32: 42-50.
21. Tezel G, Li LY, Patil RV and Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001; 42: 1787-1794.
22. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol 2007; 81: 1345- 1351.
23. Mendonca Torres PM and de Araujo EG. Interleukin- 6 increases the survival of retinal ganglion cells in vitro. J Neuroimmunol 2001; 117: 43-50.
24. Sappington RM, Chan M and Calkins DJ. Interleukin- 6 protects retinal ganglion cells from pressure-induced death. Invest Ophthalmol Vis Sci 2006; 47: 2932-2942.
25. Inomata Y, Hirata A, Yonemura N, Koga T, Kido N and Tanihara H. Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damage. Biochem Biophys Res Commun 2003; 302: 226-232.
26. Knupfer H and Preiss R. sIL-6R: more than an agonist? Immunol Cell Biol 2008; 86: 87-91.
27. Taga T and Kishimoto T. Gp130 and the interleukin- 6 family of cytokines. Annu Rev Immunol 1997; 15: 797-819.
28. Rose-John S, Scheller J, Elson G and Jones SA. Interleukin-6 biology is coordinated by membrane- bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006; 80: 227-236.
29. Hirano T, Ishihara K and Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19: 2548-2556.
30. Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, Savinova O, Roderick TH, Heckenlively JR, Davisson MT and John SW. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 1999; 21: 405-409.
31. Anderson MG, Smith RS, Hawes NL, Zabaleta A, Chang B, Wiggs JL and John SW. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet 2002; 30: 81-85.
32. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, Davisson M, Roderick TH and Heckenlively JR. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998; 39: 951- 962.
33. Inman DM, Sappington RM, Horner PJ and Calkins DJ. Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest Ophthalmol Vis Sci 2006; 47: 986 -996.
34. Weinreb RN and Khaw PT. Primary open-angle glaucoma. Lancet 2004; 363: 1711-1720.
35. Crish SD, Sappington RM, Inman DM, Horner PJ and Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A 2010; 107: 5196-5201.
36. Sappington RM, Sidorova T, Long DJ and Calkins DJ. TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Invest Ophthalmol Vis Sci 2009; 50: 717-728.
37. Choi JH and Won MH. Microglia in the normally aged hippocampus. Lab Anim Res 2011; 27: 181-187.
38. Harry GJ and Kraft AD. Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology 2012; 33: 191-206.
39. Gemma C, Bachstetter AD and Bickford PC. Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain. Aging Dis 2010; 1: 232-244.
40. Czeh M, Gressens P and Kaindl AM. The yin and yang of microglia. Dev Neurosci 2011; 33: 199- 209.
41. Soto I, Pease ME, Son JL, Shi X, Quigley HA and Marsh-Armstrong N. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest Ophthalmol Vis Sci 2011; 52: 434-441.
42. Shea TB and Chan WK. Regulation of neurofilament dynamics by phosphorylation. Eur J Neurosci 2008; 27: 1893-1901.
43. Schlamp CL, Li Y, Dietz JA, Janssen KT and Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 2006; 7: 66.
44. Filippopoulos T, Danias J, Chen B, Podos SM and Mittag TW. Topographic and morphologic analyses of retinal ganglion cell loss in old DBA/2NNia mice. Invest Ophthalmol Vis Sci 2006; 47: 1968-1974.
45. Jakobs TC, Libby RT, Ben Y, John SW and Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 2005; 171: 313-325.